Revisiting Senseonics After 4 Years: Still A Big Investment Opportunity

Senseonics is aiming to disrupt the continuous glucose monitoring (CGM) market, currently dominated by DexCom, Abbott, and Medtronic, with its newly introduced 365-day CGM system. The next year is critical for Senseonics as they evaluate their commercial partnership with Ascensia and prove the viability of their technology. Despite a previous bullish article from the author that resulted in losses for followers, the author still believes the risk/reward ratio is favorable, citing the potential for a multibagger investment.

Analysis

Senseonics (SENS) is strategically positioning itself to disrupt the continuous glucose monitoring (CGM) market with its recently introduced 365-day CGM system, aiming to compete against established short-term offerings from DexCom, Abbott Laboratories (ABT), and Medtronic (MDT). The next twelve months are critical for Senseonics, as the company must demonstrate the technological viability and market acceptance of its long-duration product. A key strategic decision also looms regarding its commercial partnership with Ascensia, with options including continuing the collaboration, finding a new partner, or pursuing independent commercialization. Despite the article's author acknowledging that a previous bullish call on SENS in March 2021 resulted in losses for followers, they currently maintain that the risk/reward ratio is favorably skewed, suggesting the stock has 'multibagger' potential. This outlook is reflected in a 'mildly positive' general sentiment score (0.3) and a more specific 'positive' sentiment for SENS (0.6), indicating a degree of optimism regarding its innovative technology and future prospects.

Key Decisions for Investors

• Investors should closely monitor Senseonics' progress in validating its 365-day CGM technology and achieving market traction over the crucial upcoming 12-month period.
• The company's decision regarding its commercial partnership with Ascensia, or any alternative commercialization strategy, will be a key determinant of its future growth trajectory and should be watched closely.
• Given the historical context of investor losses following a previous bullish call, coupled with the current 'multibagger' potential cited, SENS represents a high-risk, high-reward opportunity requiring thorough due diligence and alignment with individual risk tolerance, contingent on successful execution of its strategic objectives.